Screener
R&D at other companies
Segments
By product
Other financials
Where this comes from
Reported directly by Absci Corporation in its filing.
Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.
The source filing: Absci Corporation’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 4:24 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001672688-26-000088
| (In thousands, except for share and per share data) | For the Three Months Ended March 31, 2026 | 2025 |
|---|---|---|
| Partner program revenue | $215 | $1,179 |
| Operating expenses | ||
| Research and development | 19,275 | 16,364 |
| Selling, general and administrative | 9,058 | 9,472 |
| Depreciation and amortization | 2,728 | 3,072 |
| Total operating expenses | 31,061 | 28,908 |
| Operating loss | (30,846) | (27,729) |
| Other income (expense) |
Item 1. Unaudited Condensed Consolidated Financial Statements
FAQ
- What is Absci Corporation's R&D?
- Absci Corporation (ABSI) reported R&D of $19.28M in Q1 2026.
- How has Absci Corporation's R&D changed year-over-year?
- Absci Corporation's R&D increased by 17.8% year-over-year, from $16.36M to $19.28M.
- What is the long-term trend for Absci Corporation's R&D?
- Over 4 years (2021 to 2025), Absci Corporation's R&D has grown at a 16.2% compound annual growth rate (CAGR), from $44.59M to $81.42M.
- What does R&D mean?
- Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.
Ask your AI about Absci Corporation's r&d.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude